A proof-of-concept phase 2 study of monoclonal antibody MDX-33 in adult subjects with chronic stable ITP.

被引：0
|
作者：
Terjanian, T
Sher, H
Vemuri, R
Windsor, K
Nicolay, U
Vessey, A
Deo, Y
Curnow, R
机构：
[1] Staten Island Univ Hosp, Staten Isl, NY USA
[2] Jacksonville Oncol Grp, Jacksonville, FL USA
[3] W Michigan Canc Ctr, Kalamazoo, MI USA
[4] Birmingham Hematol Oncol Assoc, Birmingham, AL USA
[5] Aventis Behring, King Of Prussia, PA USA
[6] Medarex Inc, Annandale, NJ USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1081
引用
收藏
页码：251A / 251A
页数：1
相关论文
共 50 条
  • [1] Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study
    Ashimova, Assem
    Myngbay, Askhat
    Yegorov, Sergey
    Negmetzhanov, Baurzhan
    Kadyrova, Irina
    Yershova, Angelina
    Kart, Ulpan
    Miller, Matthew S.
    Hortelano, Gonzalo
    PHARMACEUTICS, 2022, 14 (10)
  • [2] Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip
    Conway, Janet
    Delanois, Ronald E.
    Mont, Michael A.
    Stavrakis, Alexandra
    McPherson, Edward
    Stolarski, Edward
    Incavo, Stephen
    Oakes, Daniel
    Salvagno, Ralph
    Adams, John S.
    Kisch-Hancock, Adriane
    Tenorio, Edgar
    Leighton, Anton
    Ryser, Stefan
    Kauvar, Lawrence M.
    Bernthal, Nicholas M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (08)
  • [3] Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study
    Thornton, Steven
    Miller, Hugh
    Valenzuela, Guillermo
    Snidow, Jerry
    Stier, Brendt
    Fossler, Michael J.
    Montague, Timothy H.
    Powell, Marcy
    Beach, Kathleen J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 740 - 749
  • [4] Phase 2 Proof-of-concept trial design for BIVV020, a monoclonal antibody targeting complement C1s, in CIDP
    Hughes, Richard
    Lewis, Richard
    Querol, Luis
    Hartung, Hans-Peter
    van Doorn, Pieter
    Wallstroem, Erik
    Luo, Xiaodong
    Alonso-Alonso, Miguel
    Atassi, Nazem
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 355 - 355
  • [5] Extracorporeal CO2 removal (ECCO2R) in patients with stable COPD with chronic hypercapnia: a proof-of-concept study
    Pisani, Lara
    Nava, Stefano
    Desiderio, Emilia
    Polverino, Mario
    Tonetti, Tommaso
    Ranieri, V. Marco
    THORAX, 2020, 75 (10) : 897 - 900
  • [6] SERELAXIN TO LOWER PORTAL PRESSURE (STOPP): A RANDOMIZED PHASE 2 PROOF-OF-CONCEPT STUDY
    Gifford, Fiona J.
    Dunne, Philip Dj
    Weir, Graeme
    Ireland, Hamish
    Graham, Catriona
    Tuck, Sharon
    Hayes, Peter
    Fallowfield, Jonathan Andrew
    HEPATOLOGY, 2019, 70 : 492A - 493A
  • [7] An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy
    Querol, Luis
    Lewis, Richard A.
    Hartung, Hans-Peter
    Van Doorn, Pieter A.
    Wallstroem, Erik
    Luo, Xiaodong
    Alonso-Alonso, Miguel
    Atassi, Nazem
    Hughes, Richard A. C.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 (02) : 276 - 285
  • [8] SAFETY AND EFFICACY OF VELUSETRAG IN CHRONIC INTESTINAL PSEUDO-OBSTRUCTION: PHASE II PROOF-OF-CONCEPT STUDY
    Stanghellini, Vincenzo
    Malagelada, Carolina
    De Giorgio, Roberto
    Cogliandro, Rosanna F.
    Alcala-Gonzalez, Luis G.
    Costanzini, Anna
    Grimaldi, Maria
    Giovannini, Roberto
    Gentile, Emanuela
    Scuderi, Valeria
    Manzoni, Sara
    Pasquali, Elena
    Costantini, Chiara
    Barone, Michelangelo
    Pellacani, Andrea U.
    Tack, Jan F.
    GASTROENTEROLOGY, 2024, 166 (05) : S1081 - S1081
  • [9] Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
    Becker, Clemens
    Lord, Stephen R.
    Studenski, Stephanie A.
    Warden, Stuart J.
    Fielding, Roger A.
    Recknor, Christopher P.
    Hochberg, Marc C.
    Ferrari, Serge L.
    Blain, Hubert
    Binder, Ellen F.
    Rolland, Yves
    Poiraudeau, Serge
    Benson, Charles T.
    Myers, Stephen L.
    Hu, Leijun
    Ahmad, Qasim I.
    Pacuch, Kelli R.
    Gomez, Elisa V.
    Benichou, Olivier
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (12): : 948 - 957
  • [10] Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study
    Tiseo, Paul J.
    Ren, Haobo
    Mellis, Scott
    JOURNAL OF PAIN RESEARCH, 2014, 7 : 523 - 530
12345